These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1094 related articles for article (PubMed ID: 29395949)

  • 1. Treatments, Outcomes, and Validity of Prognostic Scores in Patients With Sarcomatoid Renal Cell Carcinoma: A 20-Year Single-Institution Experience.
    Korenbaum C; Pierard L; Thiéry A; Story F; Lindner V; Lang H; Kurtz JE; Barthélémy P
    Clin Genitourin Cancer; 2018 Jun; 16(3):e577-e586. PubMed ID: 29395949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome of patients with metastatic sarcomatoid renal cell carcinoma: results from the International Metastatic Renal Cell Carcinoma Database Consortium.
    Kyriakopoulos CE; Chittoria N; Choueiri TK; Kroeger N; Lee JL; Srinivas S; Knox JJ; Bjarnason GA; Ernst SD; Wood LA; Vaishampayan UN; Agarwal N; Pal SK; Kanesvaran R; Rha SY; Yuasa T; Donskov F; North SA; Heng DY; Rini BI
    Clin Genitourin Cancer; 2015 Apr; 13(2):e79-85. PubMed ID: 25450036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sarcomatoid renal cell carcinoma: biologic behavior, prognosis, and response to combined surgical resection and immunotherapy.
    Cangiano T; Liao J; Naitoh J; Dorey F; Figlin R; Belldegrun A
    J Clin Oncol; 1999 Feb; 17(2):523-8. PubMed ID: 10080595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical outcome in patients receiving systemic therapy for metastatic sarcomatoid renal cell carcinoma: a retrospective analysis.
    Pal SK; Jones JO; Carmichael C; Saikia J; Hsu J; Liu X; Figlin RA; Twardowski P; Lau C
    Urol Oncol; 2013 Nov; 31(8):1826-31. PubMed ID: 22608544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical features and response to immune combinations in patients with renal cell carcinoma and sarcomatoid de-differentiation (ARON-1 study).
    Ciccarese C; Büttner T; Cerbone L; Zampiva I; Monteiro FSM; Basso U; Pichler M; Vitale MG; Fiala O; Roviello G; Kopp RM; Carrozza F; Pichler R; Grillone F; Calabuig EP; Zeppellini A; Küronya Z; Galli L; Facchini G; Sunela K; Mosca A; Molina-Cerrillo J; Spinelli GP; Ansari J; Scala A; Mollica V; Grande E; Buti S; Kanesvaran R; Zakopoulou R; Bamias A; Rizzo M; Massari F; Iacovelli R; Santoni M
    Int J Cancer; 2024 Dec; 155(11):2036-2046. PubMed ID: 39243397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-life experience of patients with sarcomatoid renal cell carcinoma: a multicenter retrospective study.
    Almuradova E; Basoglu T; Nayir E; Bayram E; Paydas S; Gokmen I; Karakaya S; Oksuzoglu B; Erdem D; Sakin A; Atcı M; Belen Gulbagcı B; Hacibekiroglu I; Onder AH; Karaarslan S; Karakurt Eryılmaz M; Korkmaz M; Yazıcı O; Sutcuoglu O; Akagunduz B; Arak H; Sakalar T; Aydin D; Iriagac Y; Alan O; Midik M; Cetin D; Kip AD; Turhal S; Kacan T; Koseci T
    Neoplasma; 2023 Feb; 70(1):158-165. PubMed ID: 36620878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real-world Assessment of Clinical Outcomes in Patients with Metastatic Renal Cell Carcinoma with or Without Sarcomatoid Features Treated with First-line Systemic Therapies.
    Sawaya GB; Dragomir A; Wood LA; Kollmannsberger C; Basappa NS; Kapoor A; Soulières D; Finelli A; Heng DYC; Castonguay V; Canil C; Winquist E; Graham J; Bjarnason GA; Bhindi B; Lalani AK; Pouliot F; Breau RH; Saleh R; Tanguay S
    Eur Urol Oncol; 2024 Jun; 7(3):570-580. PubMed ID: 38097481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using percentage of sarcomatoid differentiation as a prognostic factor in renal cell carcinoma.
    Kim T; Zargar-Shoshtari K; Dhillon J; Lin HY; Yue B; Fishman M; Sverrisson EF; Spiess PE; Gupta S; Poch MA; Sexton WJ
    Clin Genitourin Cancer; 2015 Jun; 13(3):225-30. PubMed ID: 25544725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of pathological tumour characteristics in patients with sarcomatoid renal cell carcinoma.
    Shuch B; Bratslavsky G; Shih J; Vourganti S; Finley D; Castor B; Treat E; Linehan WM; Pantuck AJ; Said JW; Belldegrun AS
    BJU Int; 2012 Jun; 109(11):1600-6. PubMed ID: 22221668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotherapy in metastatic sarcomatoid renal cell carcinoma: A single institution experience.
    Park JJ; Kellezi O; Hamasha R; Ali A; Alva AS
    Cancer Treat Res Commun; 2020; 25():100251. PubMed ID: 33310369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of glandular metastases on overall survival of patients with metastatic clear cell renal cell carcinoma in the antiangiogenic therapy era.
    Gravis G; Chanez B; Derosa L; Beuselinck B; Barthelemy P; Laguerre B; Brachet PE; Joly F; Escudier B; Harrison DJ; Laird A; Vasudev N; Ralph C; Larkin J; Lote H; Salem N; Walz J; Thomassin J; Sfumato P; Stewart GD; Boher JM;
    Urol Oncol; 2016 Apr; 34(4):167.e17-23. PubMed ID: 26670200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Checkpoint inhibitors in patients with metastatic renal cell carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium.
    Yip SM; Wells C; Moreira R; Wong A; Srinivas S; Beuselinck B; Porta C; Sim HW; Ernst DS; Rini BI; Yuasa T; Basappa NS; Kanesvaran R; Wood LA; Canil C; Kapoor A; Fu SYF; Choueiri TK; Heng DYC
    Cancer; 2018 Sep; 124(18):3677-3683. PubMed ID: 30307610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of histologic subtype and sarcomatoid transformation on metastasis in renal cell carcinoma: a single institute experience in 149 patients.
    Tirumani SH; Souza D; Krajewski KM; Jagannathan JP; Ramaiya NH; Shinagare AB
    Abdom Radiol (NY); 2016 Feb; 41(2):295-302. PubMed ID: 26867911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stage migration and increasing proportion of favorable-prognosis metastatic renal cell carcinoma patients: implications for clinical trial design and interpretation.
    Patil S; Ishill N; Deluca J; Motzer RJ
    Cancer; 2010 Jan; 116(2):347-54. PubMed ID: 19921736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The International Metastatic Renal Cell Carcinoma Database Consortium model as a prognostic tool in patients with metastatic renal cell carcinoma previously treated with first-line targeted therapy: a population-based study.
    Ko JJ; Xie W; Kroeger N; Lee JL; Rini BI; Knox JJ; Bjarnason GA; Srinivas S; Pal SK; Yuasa T; Smoragiewicz M; Donskov F; Kanesvaran R; Wood L; Ernst DS; Agarwal N; Vaishampayan UN; Rha SY; Choueiri TK; Heng DY
    Lancet Oncol; 2015 Mar; 16(3):293-300. PubMed ID: 25681967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utilizing pre-therapy clinical schema and initial CT changes to predict progression-free survival in patients with metastatic renal cell carcinoma on VEGF-targeted therapy: a preliminary analysis.
    Smith AD; Shah SN; Rini BI; Lieber ML; Remer EM
    Urol Oncol; 2013 Oct; 31(7):1283-91. PubMed ID: 21956044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overall survival after immunotherapy, tyrosine kinase inhibitors and surgery in treatment of metastatic renal cell cancer: outcome of 143 consecutive patients from a single centre.
    De Lichtenberg TH; Hermann GG; Rørth M; Højer Larsen MJ; Mansourvar Z; Holm ML; Scheike T
    Scand J Urol; 2014 Aug; 48(4):379-86. PubMed ID: 24521185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Percentage of sarcomatoid component as a prognostic indicator for survival in renal cell carcinoma with sarcomatoid dedifferentiation.
    Adibi M; Thomas AZ; Borregales LD; Merrill MM; Slack RS; Chen HC; Sircar K; Murugan P; Tamboli P; Jonasch E; Tannir NM; Matin SF; Wood CG; Karam JA
    Urol Oncol; 2015 Oct; 33(10):427.e17-23. PubMed ID: 26004164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
    Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
    BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors of metastatic renal cell carcinoma with extensive sarcomatoid component.
    Park I; Cho YM; Lee JL; Ahn JH; Lee DH; Song C; Hong JH; Kim CS; Ahn H
    J Cancer Res Clin Oncol; 2013 May; 139(5):817-27. PubMed ID: 23397357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 55.